115 related articles for article (PubMed ID: 1465038)
21. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
[TBL] [Abstract][Full Text] [Related]
22. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
[TBL] [Abstract][Full Text] [Related]
23. Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study.
Eriksen PS; Rasmussen H
Eur J Obstet Gynecol Reprod Biol; 1992 Apr; 44(2):137-44. PubMed ID: 1587379
[TBL] [Abstract][Full Text] [Related]
24. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
Buckler H; Al-Azzawi F;
BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
[TBL] [Abstract][Full Text] [Related]
25. Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal Women.
Constantine GD; Bouchard C; Pickar JH; Archer DF; Graham S; Bernick B; Mirkin S
J Womens Health (Larchmt); 2017 Jun; 26(6):616-623. PubMed ID: 28355090
[TBL] [Abstract][Full Text] [Related]
26. Effect on endometrial histology and pharmacokinetics of different dose regimens of progesterone vaginal pessaries, in comparison with progesterone vaginal gel and placebo.
Duijkers IJM; Klingmann I; Prinz R; Wargenau M; Hrafnsdottir S; Magnusdottir TB; Klipping C
Hum Reprod; 2018 Nov; 33(11):2131-2140. PubMed ID: 30265306
[TBL] [Abstract][Full Text] [Related]
27. Endometrial safety of ultra-low-dose Vagifem 10 microg in postmenopausal women with vaginal atrophy.
Ulrich LS; Naessen T; Elia D; Goldstein JA; Eugster-Hausmann M;
Climacteric; 2010 Jun; 13(3):228-37. PubMed ID: 20423243
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
[TBL] [Abstract][Full Text] [Related]
29. An open-label randomized trial to determine the most effective regimen of vaginal estrogen to reduce the prevalence of atrophic changes reported in postmenopausal cervical smears.
Bateson DJ; Weisberg E
Menopause; 2009; 16(4):765-9. PubMed ID: 19407678
[TBL] [Abstract][Full Text] [Related]
30. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):907-22. PubMed ID: 19436225
[TBL] [Abstract][Full Text] [Related]
31. Surgical management of pelvic organ prolapse in women: a short version Cochrane review.
Maher C; Baessler K; Glazener CM; Adams EJ; Hagen S
Neurourol Urodyn; 2008; 27(1):3-12. PubMed ID: 18092333
[TBL] [Abstract][Full Text] [Related]
32. The effect of prolapse surgery on vaginal sensibility.
Lakeman MM; van der Vaart CH; Laan E; Roovers JP
J Sex Med; 2011 Apr; 8(4):1239-45. PubMed ID: 21235724
[TBL] [Abstract][Full Text] [Related]
33. The relationships between vaginal collagen, plasma oestradiol and uterine prolapse in turkeys.
Buchanan S; Robertson GW; Hocking PM
Res Vet Sci; 1999 Oct; 67(2):153-7. PubMed ID: 10502485
[TBL] [Abstract][Full Text] [Related]
34. Menopause leading to increased vaginal wall thickness in women with genital prolapse: impact on sexual response.
da Silva Lara LA; da Silva AR; Rosa-E-Silva JC; Chaud F; Silva-de-Sá MF; Meireles E Silva AR; de Sá Rosa-E-Silva AC
J Sex Med; 2009 Nov; 6(11):3097-110. PubMed ID: 19656272
[TBL] [Abstract][Full Text] [Related]
35. [Continuous, low dosage estradiol administration with a vaginal ring: a placebo-controlled study].
Casper F; Petri E; Benninghoff B
Zentralbl Gynakol; 1998; 120(9):449-53. PubMed ID: 9796090
[TBL] [Abstract][Full Text] [Related]
36. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
Crandall C
J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
[TBL] [Abstract][Full Text] [Related]
37. Patient acceptability and satisfaction with a low-dose solubilized vaginal estradiol softgel capsule, TX-004HR.
Kingsberg SA; Kroll R; Goldstein I; Kushner H; Bernick B; Graham S; Mirkin S; Constantine GD
Menopause; 2017 Aug; 24(8):894-899. PubMed ID: 28195995
[TBL] [Abstract][Full Text] [Related]
38. The effects of vaginal prolapse surgery using synthetic mesh on vaginal wall sensibility, vaginal vasocongestion, and sexual function: a prospective single-center study.
Weber MA; Lakeman MM; Laan E; Roovers JP
J Sex Med; 2014 Jul; 11(7):1848-55. PubMed ID: 24735345
[TBL] [Abstract][Full Text] [Related]
39. Genital prolapse in women.
Onwude JL
BMJ Clin Evid; 2007 Mar; 2007():. PubMed ID: 19454058
[TBL] [Abstract][Full Text] [Related]
40. Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design.
Oppegaard KS; Nesheim BI; Istre O; Qvigstad E
BJOG; 2007 Jun; 114(6):769, e1-12. PubMed ID: 17516971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
